Zomig

Product manufactured by Amneal Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA020768 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zomig Is Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use • Only Use Zomig If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To Zomig Treatment For The First Migraine Attack, Reconsider The Diagnosis Of Migraine Before Zomig Is Administered To Treat Any Subsequent Attacks. • Zomig Is Not Indicated For The Prevention Of Migraine Attacks. • Safety And Effectiveness Of Zomig Have Not Been Established For Cluster Headache. Zomig Is A Serotonin (5-Ht) 1b/1d Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults (1) Limitations Of Use : • Use Only After A Clear Diagnosis Of Migraine Has Been Established (1) • Not Indicated For The Prophylactic Therapy Of Migraine (1) • Not Indicated For The Treatment Of Cluster Headache (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Zolmitriptan ZOLMITRIPTAN ZINC15515

Comments